Oxford Asset Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Oxford Asset Management’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-71,069	Closed	-$216K	–	2252
2019 Q3	$216K	Buy	+71,069	New	+$200K	0.01%	1558
2019 Q2	–	Sell	-54,582	Closed	-$205K	–	2079
2019 Q1	$205K	Sell	54,582 -93,173	-63%	-$349K	﹤0.01%	1508
2018 Q4	$530K	Sell	147,755 -42,898	-23%	-$187K	0.01%	1173
2018 Q3	$1.09M	Buy	+190,653	New	+$1.09M	0.02%	966

Other funds holding FOMX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Oxford Asset Management's FOMX Position: Q4 2019 in Review

Oxford Asset Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2019, closing a stake of 71,069 shares — an estimated $216K sold.

Oxford Asset Management first reported a position in FOMX in Q3 2018 and held it in 4 quarters. The position peaked at $1.09M in Q3 2018. 65 funds tracked by Wall St. Rank hold FOMX as of Q4 2019.

Oxford Asset Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2019 after selling out during the quarter.
Oxford Asset Management sold 71,069 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2019, an estimated $216K.
Oxford Asset Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2018 and held it in 4 quarters.
Oxford Asset Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $1.09M in Q3 2018.
65 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.